- Home
- LAB vs GBAB Comparison
LAB vs GBAB Comparison
Compare LAB & GBAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LAB | GBAB |
|---|---|---|
| Founded | 1999 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Investment Managers |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 488.4M | 412.4M |
| IPO Year | 2011 | N/A |
Fundamental Metrics
Financial Performance| Metric | LAB | GBAB |
|---|---|---|
| Price | $1.13 | $15.43 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $1.35 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 69.4K |
| Earning Date | 02-24-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.18% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $169,737,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 79.77 | N/A |
| 52 Week Low | $0.92 | $14.22 |
| 52 Week High | $1.72 | $17.44 |
Technical Indicators
Market Signals| Indicator | LAB | GBAB |
|---|---|---|
| Relative Strength Index (RSI) | 29.39 | 61.94 |
| Support Level | $1.10 | $14.93 |
| Resistance Level | $1.46 | $15.45 |
| Average True Range (ATR) | 0.08 | 0.17 |
| MACD | -0.03 | 0.04 |
| Stochastic Oscillator | 6.98 | 94.00 |
Price Performance
Historical ComparisonAbout LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.
About GBAB Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust of Beneficial Interest
Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust is a diversified closed-end management investment company. Its investment objective is to provide current income with a secondary objective of long-term capital appreciation. Its products include Mutual funds, Unit investment trusts, Closed-end funds, Rydex funds, Credit income fund and others.